Results 201 to 210 of about 61,846 (265)
Some of the next articles are maybe not open access.
Esophageal acid sensitivity and mucosal integrity in patients with functional heartburn
Neurogastroenterology and Motility, 2016Pim Weijenborg
exaly +2 more sources
AGA Clinical Practice Update on Functional Heartburn: Expert Review.
Gastroenterology, 2020Best Practice Advice 1 A diagnosis of functional heartburn should be considered when retrosternal burning pain or discomfort persists despite maximal (double-dose) proton pump inhibitor (PPI) therapy taken appropriately before meals during a 3-month ...
R. Fass, F. Zerbib, C. Gyawali
semanticscholar +1 more source
Current Treatment Options in Gastroenterology, 2005
Functional heartburn (FH) is a common disorder that accounts for 30% to 50% of the patients with nonerosive reflux disease. FH is composed from a heterogeneous group of patients. They primarily include the hypersensitive and the nonacid sensitive esophagus.
Ram, Dickman, Ronnie, Fass
openaire +2 more sources
Functional heartburn (FH) is a common disorder that accounts for 30% to 50% of the patients with nonerosive reflux disease. FH is composed from a heterogeneous group of patients. They primarily include the hypersensitive and the nonacid sensitive esophagus.
Ram, Dickman, Ronnie, Fass
openaire +2 more sources
Current Treatment Options in Gastroenterology, 2002
Functional heartburn is defined as the presence of a retrosternal burning sensation in the absence of pathologic gastroesophageal reflux. The underlying pathophysiology seems to be heterogeneous. In a subset of patients, esophageal hypersensitivity to physiologic esophageal acid exposure is involved, and this is likely to respond to intensive ...
Jan, Tack, Jozef, Janssens
openaire +2 more sources
Functional heartburn is defined as the presence of a retrosternal burning sensation in the absence of pathologic gastroesophageal reflux. The underlying pathophysiology seems to be heterogeneous. In a subset of patients, esophageal hypersensitivity to physiologic esophageal acid exposure is involved, and this is likely to respond to intensive ...
Jan, Tack, Jozef, Janssens
openaire +2 more sources
Journal of the American Medical Association, 1949
All physicians encounter patients who have symptoms that are difficult to treat because the mechanisms which produce them are poorly understood. Gastroenterologists deal with a number of such symptoms, among which may be listed not only the many varieties of abdominal pain but also such complaints as belching, flatulence, malodorous breath, a bad taste
H J, TUMEN, E M, COHN
openaire +2 more sources
All physicians encounter patients who have symptoms that are difficult to treat because the mechanisms which produce them are poorly understood. Gastroenterologists deal with a number of such symptoms, among which may be listed not only the many varieties of abdominal pain but also such complaints as belching, flatulence, malodorous breath, a bad taste
H J, TUMEN, E M, COHN
openaire +2 more sources
Neurogastroenterology and Motility, 2020
When esophageal acid exposure time (AET) is physiologic, ROME IV stratifies functional esophageal disorders into functional heartburn (FH, with negative reflux‐symptom association) and reflux hypersensitivity (RH, with positive reflux‐symptom association)
A. Rengarajan +3 more
semanticscholar +1 more source
When esophageal acid exposure time (AET) is physiologic, ROME IV stratifies functional esophageal disorders into functional heartburn (FH, with negative reflux‐symptom association) and reflux hypersensitivity (RH, with positive reflux‐symptom association)
A. Rengarajan +3 more
semanticscholar +1 more source
Refractory Gastroesophageal Reflux Disease and Functional Heartburn.
Gastrointestinal Endoscopy Clinics of North America, 2020This report discusses the potential mechanisms that might underlie refractory GERD and functional heartburn, and how to distinguish among those mechanisms using a systematic evaluation that includes careful medical history, endoscopy with esophageal ...
S. Spechler
semanticscholar +1 more source
New York clinical trial quietly tests heartburn remedy against coronavirus
, 2020The fast-growing list of possible treatments for the novel coronavirus includes an unlikely candidate: famotidine, the active compound in the over-the-counter heartburn drug Pepcid On 7 April, the first COVID-19 patients at Northwell Health in the New ...
B. Borrell
semanticscholar +1 more source